Avidity Biosciences, Inc.
Beta-catenin nucleic acids and uses thereof

Abstract:

Disclosed herein are molecules and pharmaceutical compositions that mediate RNA interference against CTNNB1. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that mediate RNA interference against CTNNB1.